SCHEMBL7080374

SCHEMBL7080374

Cc1ccc(N2CCC(NC(=O)OC(C)(C)C)CC2)nc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 1/20 0.61
SKP1 P63208 1/20 0.61
SKP2 Q13309 1/20 0.61
SYK P43405 2/20 0.51
RET P07949 1/20 0.51
HRH3 Q9Y5N1 1/20 0.47
PDE10A Q9Y233 2/20 0.46
MAPK8 P45983 1/20 0.46
MAP4K4 O95819 2/20 0.46
SMO Q99835 1/20 0.45
SUV39H2 Q9H5I1 1/20 0.44
GPR119 Q8TDV5 2/20 0.44
JAK3 P52333 1/20 0.44
BTK Q06187 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
KCNA3 P22001 1/20 0.43
CTSK P43235 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30931884 0.88 CKS1B (0.61) CKS1BSKP1SKP2SYKRET
SCHEMBL21564581 0.88 CKS1B (0.61) CKS1BSKP1SKP2SYKRET
SCHEMBL530038 0.88 CKS1B (0.61) CKS1BSKP1SKP2SYKRET
SCHEMBL29518126 0.87 CKS1B (0.60) CKS1BSKP1SKP2SYKRET
SCHEMBL21360327 0.87 CKS1B (0.60) CKS1BSKP1SKP2SYKRET
SCHEMBL23323204 0.87 CKS1B (0.60) CKS1BSKP1SKP2SYKRET
SCHEMBL28666722 0.87 CKS1B (0.60) CKS1BSKP1SKP2SYKRET
SCHEMBL3025692 0.87 CKS1B (0.60) CKS1BSKP1SKP2SYKRET
SCHEMBL31722428 0.87 CKS1B (0.60) CKS1BSKP1SKP2SYKRET
SCHEMBL6139645 0.86 CKS1B (0.61) CKS1BSKP1SKP2SYKRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6649627-B1 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea SANOFI-SYNTHELABO (FR) 2003-11-18 US disclosed